| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 |
| Total Revenue |
-
|
-
|
| Cost of Revenue |
-
|
-
|
|
| Gross Profit |
-
|
-
|
|
| Operating Expenses |
| Research Development |
-
|
-
|
| Selling General and Administrative | 87 | 173 |
| Non Recurring |
-
|
-
|
| Others |
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
|
|
| Operating Income or Loss | (87) | (173) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 13 | 11 |
| Earnings Before Interest And Taxes | (74) | (162) |
| Interest Expense | 88 | 114 |
| Income Before Tax | (162) | (277) |
| Income Tax Expense |
-
|
-
|
| Minority Interest |
-
|
-
|
| |
| Net Income From Continuing Ops | (162) | (277) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
| Extraordinary Items |
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
| Other Items |
-
|
-
|
|
|
| Net Income | (162) | (277) |
| Preferred Stock And Other Adjustments |
-
|
-
|
|
| Net Income Applicable To Common Shares | ($162) | ($277) |
0.63% Nasdaq 
0.03%
Income Statement
